Our Researchers | LLNI Funding 2024
Successful new treatments, repurposed drugs or new drug combinations can then be used in clinical trials and ultimately can be offered by Haematology consultants as new, specialised treatments for their patients.
Katrina Lappin
LLNI Fellow exploring immune activation in MDS and AML, and how we can exploit the immune response to target leukaemic cells.
Graeme Greenfield
Academic Clinical Fellow. How do individual AML cells adapt to avoid cell death after treatment with azacitidine and venetoclax in individual patients.
Hayley McMillan
Understanding the genetic mutations in myeloid malignancies at diagnosis and during disease progression, and to also identify specific drug combinations that inhibit these mutations.
Jonathan Morgan
Post Doc Researcher Understanding the role of the HUWE1 protein in Multiple Myeloma and to evaluates its potential as a target in the treatment of the disease.
Lydia Roets
CURED Study Characterising drivers of therapeUtic Resistance in paEDiatric AML (CURED study).
Our PhD Researchers 2024
LLNI currently funds 5 PHD students with 2 more starting in September 2024.
Alex Mutch PhD
Genetic dependencies of spliceosome mutated myelodysplastic syndromes and acute myeloid leukaemia.
Chloe Wylie PhD
Exosome-mediated molecular mechanisms in the progression of multiple myeloma.
Edward Tang PhD
Understanding primary chemotherapy resistance in childhood acute myeloid leukaemia.
Beth McCrea PhD
Developing small molecule inhibitors to target HUWE1 mutation.
Rebecca Briggs PhD
Investigating immune activation in myelodysplastic syndromes and acute myeloid leukaemia in the hope of identifying new treatment strategies for patients.
Scientific and Medical Committee
A panel of independent researchers and clinicians who provide recommendations to Leukaemia & Lymphoma NI on decisions relating to the funding and management of research projects.
Dr Kathryn Clarke
Vice Chair
Principal Clinical Scientist | Haemato-oncology Department of Haematology Belfast City Hospital
Dr Aaron Niblock
Chair
Haematology Consultant Antrim Hospital
Dr Lynn McCallum
Associate Professor in Haematology (Education) Programme Lead Healthcare Sciences University of Plymouth Programme Lead Applied Biomedical Sciences Programme Lead Clinical Physiology
Dr Brídgín Merron
Glenda Joanne Dickson
Principal Scientist, Innovation Virocell
They ensure that all LLNI funding awards support the highest quality research and will consider applications for funding for basic, translational and clinical related research.